| Aktientyp | Stammaktie |
Zahlen für Q2/20
Mit ATM Offering versucht sich das Unternehmen über Wasser zu halten.
"In May 2020, the Company raised $5.0 million in a registered direct offering of 16,291,952 ordinary shares at a purchase price of $0.3069 per share."
https://ir.intecpharma.com/news-releases/news-release-details/intec-pharma-reports-second-quarter-2020-financial-results-and
6,5 Mio. $ Offering
https://ir.intecpharma.com/news-releases/news-release-details/intec-pharma-announces-pricing-65-million-public-offering
Zahlen für Q3/19
https://ir.intecpharma.com/news-releases/news-release-details/intec-pharma-reports-third-quarter-2019-financial-results-and